Inhibikase Therapeutics to Present at the Sidoti Micro-Cap Virtual Conference
- Thursday, May 4, 2023, 7:10
- Business
- Add a comment
BOSTON and ATLANTA, May 4, 2023 /PRNewswire/ — Inhibikase Therapeutics, Inc. (Nasdaq: IKT) (“Inhibikase” or “Company”), a clinical-stage pharmaceutical company developing protein kinase inhibitor therapeutics to modify the course of Parkinson’s disease, Parkinson’s-related disorders and…
About the Author
adminasapcorp has written 41558 stories on this site.